Regeneron’s antibody cocktail, Kevzara, is now available for people with moderate to severe rheumatoid arthritis. Kevzara is a combination of three antibodies that block different chemicals involved in the inflammation process.

The cocktail was approved by the U.S. Food and Drug Administration in May of 2017 and has been shown to be more effective than older drugs in reducing inflammation and slowing disease progression. Kevzara is administered as an injection every two weeks.

Regeneron has not released the price of …